MELANIE FRIERSON: Open Payments
NPI 1720659758 · PICAYUNE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 26 payments from 10 companies in 2025. Trend: 2023 $236 · 2024 $2,270 · 2025 $547
Food & beverage: $547
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 11 | $149 |
| SANOFI-AVENTIS U.S. LLC | 2 | $121 |
| Novo Nordisk Inc | 4 | $70 |
| Lilly USA, LLC | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Dexcom, Inc. | 1 | $31 |
| Corcept Therapeutics | 1 | $31 |
| Sequel Med Tech, LLC | 1 | $29 |
| Bard Peripheral Vascular, Inc. | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: GVOKE HYPOPEN, TZIELD, Ozempic, MOUNJARO, Dexcom G6 Transmitter, Korlym, TWIIST, RotarexS 6 F x 135 cm.
Industry payments across MS — which companies pay providers there.
